×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| RPG LIFE SCIENCES LTD. | 1741.5 | 262.9 | 1689.2 | 0 | 3,813 | 36.8 |
| Orchid Pharma Limited | 1888.59 | 181.97 | 1729.29 | 3.59 | 3659 | 42.9 |
| GUFIC BIOSCIENCES LTD. | 2278.06 | 120.73 | 2269.11 | 1.2 | 3590 | 58.0 |
RPG Life Sciences Limited, with Security Code 532983, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 118.5 | 147.8 | 153.6 | 153.7 | 127.0 | 165.4 | 172.2 | 172.7 | 143.1 | 168.9 |
| Expenses | 102.6 | 115.5 | 116.3 | 115.8 | 106.3 | 126.4 | 126.3 | 123.6 | 117.6 | 133.5 |
| Operating Profit | 15.9 | 32.2 | 37.3 | 37.9 | 20.7 | 39.1 | 45.9 | 49.2 | 25.5 | 35.5 |
| OPM % | 13.43% | 21.82% | 24.28% | 24.66% | 16.32% | 23.62% | 26.67% | 28.46% | 17.85% | 21% |
| Other Income | 1.8 | 1.8 | 1.8 | 1.9 | 1.7 | 2.4 | -25.4 | 3.3 | 115.0 | 5.2 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 |
| Depreciation | 3.9 | 4.2 | 4.2 | 4.1 | 4.5 | 5.3 | 5.3 | 5.5 | 5.4 | 5.1 |
| Profit before tax | 13.8 | 29.8 | 34.8 | 35.5 | 17.7 | 36.0 | 42.4 | 46.9 | 25.1 | 35.4 |
| Tax % | -25.1% | -25.8% | -25.7% | -25.5% | -25.4% | 25.7% | 72.2% | 25.5% | -13% | 25.8% |
| Net Profit | 10.4 | 22.1 | 25.9 | 26.5 | 13.2 | 26.8 | 4.2 | 34.9 | 117.4 | 26.3 |
| EPS in Rs | 6.26 | 13.36 | 15.64 | 16 | 8.01 | 16.18 | 2.54 | 21.12 | 70.96 | 15.9 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 14% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 63% |
| 5 Years: | 29% |
| 3 Years: | 32% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 55% |
| 3 Years: | 64% |
| 1 Year: | 47% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|